JP2023532681A5 - - Google Patents

Info

Publication number
JP2023532681A5
JP2023532681A5 JP2022580239A JP2022580239A JP2023532681A5 JP 2023532681 A5 JP2023532681 A5 JP 2023532681A5 JP 2022580239 A JP2022580239 A JP 2022580239A JP 2022580239 A JP2022580239 A JP 2022580239A JP 2023532681 A5 JP2023532681 A5 JP 2023532681A5
Authority
JP
Japan
Prior art keywords
xyl
rha
fuc
saponin
glc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022580239A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023532681A (ja
Filing date
Publication date
Priority claimed from PCT/EP2020/071045 external-priority patent/WO2021014019A1/en
Application filed filed Critical
Priority claimed from PCT/EP2021/067227 external-priority patent/WO2021260054A2/en
Publication of JP2023532681A publication Critical patent/JP2023532681A/ja
Publication of JP2023532681A5 publication Critical patent/JP2023532681A5/ja
Pending legal-status Critical Current

Links

JP2022580239A 2020-06-24 2021-06-23 改善された治療濃度域を有するサポニン誘導体 Pending JP2023532681A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
NL2025904 2020-06-24
NL2025904 2020-06-24
PCT/EP2020/071045 WO2021014019A1 (en) 2019-07-25 2020-07-24 Saponin derivatives with improved therapeutic window
EPPCT/EP2020/071045 2020-07-24
PCT/EP2021/067227 WO2021260054A2 (en) 2020-06-24 2021-06-23 Saponin derivatives with improved therapeutic window

Publications (2)

Publication Number Publication Date
JP2023532681A JP2023532681A (ja) 2023-07-31
JP2023532681A5 true JP2023532681A5 (https=) 2024-06-27

Family

ID=79282018

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022580237A Pending JP2023532680A (ja) 2020-06-24 2021-06-23 改善された治療濃度域を有するサポニン誘導体
JP2022580239A Pending JP2023532681A (ja) 2020-06-24 2021-06-23 改善された治療濃度域を有するサポニン誘導体

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2022580237A Pending JP2023532680A (ja) 2020-06-24 2021-06-23 改善された治療濃度域を有するサポニン誘導体

Country Status (10)

Country Link
US (2) US20230365617A1 (https=)
EP (2) EP4171639A2 (https=)
JP (2) JP2023532680A (https=)
KR (2) KR20230043113A (https=)
CN (2) CN116390932A (https=)
AU (2) AU2021295868A1 (https=)
CA (2) CA3184027A1 (https=)
IL (2) IL299359A (https=)
MX (1) MX2022016485A (https=)
WO (2) WO2021260054A2 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20230043118A (ko) * 2020-06-24 2023-03-30 사프렘 테크놀로지스 비.브이. 사포닌 및 단일-도메인 항체의 접합체, 상기 접합체를 포함하는 약학적 조성물, 이의 치료 용도
WO2024005485A1 (ko) * 2022-06-26 2024-01-04 기초과학연구원 사포닌 유도체 화합물 및 이를 포함하는 코로나바이러스 감염증의 예방 또는 치료용 약학적 조성물
KR102887798B1 (ko) * 2022-06-26 2025-11-18 기초과학연구원 사포닌 유도체 화합물 및 이를 포함하는 코로나바이러스 감염증의 예방 또는 치료용 약학적 조성물
CN119423084B (zh) * 2024-11-07 2025-10-24 四川省烟草公司攀枝花市公司 川续断皂苷乙在蚜虫防治中的应用及杀蚜剂

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5583112A (en) 1987-05-29 1996-12-10 Cambridge Biotech Corporation Saponin-antigen conjugates and the use thereof
US5273965A (en) * 1992-07-02 1993-12-28 Cambridge Biotech Corporation Methods for enhancing drug delivery with modified saponins
US5650398A (en) * 1992-07-02 1997-07-22 Cambridge Biotech Corporation Drug delivery enhancement via modified saponins
AU3724495A (en) * 1994-09-13 1996-03-29 Prizm Pharmaceuticals, Inc. Conjugates of heparin-binding epidermal growth factor-like growth factor with targeted agents
JPH11505805A (ja) * 1995-05-16 1999-05-25 プリズム ファーマシューティカルズ,インコーポレイテッド 治療的処置のための核酸およびリガンドを含有する組成物
DE69828507T2 (de) * 1997-05-20 2006-01-05 Galenica Pharmaceuticals, Inc. Triterpene-saponin analoga mit adjuvans und immunostimulierender wirkung
US6080725A (en) * 1997-05-20 2000-06-27 Galenica Pharmaceuticals, Inc. Immunostimulating and vaccine compositions employing saponin analog adjuvants and uses thereof
WO2003037275A2 (en) * 2001-10-31 2003-05-08 Corixa Corporation Compositions and methods for viral delivery
JP2005525344A (ja) * 2002-02-04 2005-08-25 コリクサ コーポレイション アミノアルキルグルコサミニドホスフェートおよびサポニンを含む免疫刺激性組成物
WO2004092329A2 (en) * 2003-04-08 2004-10-28 Galenica Pharmaceuticals, Inc. Semi-synthetic saponin analogs with carrier and immune stimulatory activities for dna and rna vaccines
EP1623715B1 (en) * 2004-07-13 2012-09-19 Charité - Universitätsmedizin Berlin A composition comprising a pharmacologically active agent coupled to a target cell specific component, and a saponin
WO2009143345A2 (en) * 2008-05-22 2009-11-26 University Of Massachusetts Nucleic acid silencing agent-protein conjugates and use thereof for treating hcv-related disorders
CN105658230B (zh) * 2013-08-29 2020-04-21 希望之城 细胞穿透缀合物及其使用方法
KR102424785B1 (ko) 2014-05-30 2022-07-25 메모리얼 슬로안 케터링 캔서 센터 최소 사포닌 유사체, 이의 합성법 및 용도
EP3356371A4 (en) * 2015-09-29 2020-06-24 The University of Chicago POLYMER CONJUGATE VACCINE
WO2017190020A1 (en) * 2016-04-28 2017-11-02 The Scripps Research Institute Oligonucleotide conjugates and uses thereof
PE20210255A1 (es) * 2016-12-01 2021-02-10 Takeda Pharmaceuticals Co Dinucleotido ciclico como agonistas de sting (estimulador de genes de interferon)
US11708388B2 (en) * 2017-07-11 2023-07-25 Freie Universität Berlin Uses of a saponin and method for its isolation
SG11202106603UA (en) * 2018-12-21 2021-07-29 Sapreme Tech Bv Biologically active cluster of molecules
EP4003425A2 (en) * 2019-07-25 2022-06-01 Sapreme Technologies B.V. Bioactive saponin linked to a functional moiety

Similar Documents

Publication Publication Date Title
JP2023532681A5 (https=)
Chen et al. Voglibose (Basen®, AO-128), one of the most important α-glucosidase inhibitors
JP2022542075A5 (https=)
US5017566A (en) Redox systems for brain-targeted drug delivery
US11021506B2 (en) Thiosaccharide mucolytic agents
WO2011075953A1 (zh) 多臂聚乙二醇衍生物及其与药物的结合物和凝胶
TWI326687B (en) Amide prodrug of gemcitabine, compositions and use thereof
CA2556169A1 (en) Use of amino-oxy functional groups in the preparation of vaccines
WO2010060260A1 (zh) 新型的多臂聚乙二醇及其制备方法和应用
PT1593670E (pt) 2-azetidinonas substituídas com hidroxi úteis como agentes hipocolesterolémicos
JP2000516224A (ja) 修飾オリゴサッカライド
US7812006B2 (en) Conjugates obtained by reductive amination of the pneumococcus serotype 5 capsular polysaccharide
CN108350014A (zh) 氨基糖苷衍生物及其在治疗遗传性病症中的应用
JP2018528211A5 (https=)
CA2272701C (en) Glycolipid mimics and methods of use thereof
JPH11508564A (ja) 合成n−結合グリココンジュゲートを製造するための方法
US7582737B2 (en) Orthogonally protected disaccharide building blocks for synthesis of heparin oligosaccharides
JP2023533693A5 (https=)
JP2001500901A (ja) 抗腫瘍および駆虫剤を溶解するために特に利用されるチオウレイド―シクロデキストリン、およびその製造方法
JP2005041817A (ja) クルクミノイド配糖体、及びその製造方法
US20070021380A1 (en) Novel drug delivery compositions
CN111593080B (zh) 一种α-半乳糖抗原活性前体及其合成方法和应用
JP2023542500A5 (https=)
JP2000191685A (ja) コレスタノール化合物及びこれを含有する医薬
HUT74623A (en) Novel oligosaccharide-containing 14-aminosteroid compounds, pharmaceutical compositions containing the same and novel diastereoselective aminosteroid process for producing them